WELL Health Technologies Corp (TSE:WELL) has released an update.
WELL Health Technologies Corp. reports a 42% year-over-year increase in Q2-2024 revenues, reaching $243.1 million due to strong organic growth and strategic acquisitions. The company also announces a raised annual revenue guidance to between $970 million and $990 million, while maintaining a robust Adjusted EBITDA forecast. WELL’s sustained momentum is marked by a record 1.4 million patient visits in the quarter, underscoring its successful technology-driven healthcare platforms.
For further insights into TSE:WELL stock, check out TipRanks’ Stock Analysis page.
